After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Why Trump is killing biotech stocks, the Shire-for-Radius rumor makes no sense and Bernie Sanders gets a tweeting lesson.
Given the biotech's growth prospects and pipeline assets, its shares seem greatly undervalued.
Baxter reports its third-quarter earnings Tuesday.
Each company has approaching catalysts.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.